Fig. 3From: BSA modification of bacterial surface: a promising anti-cancer therapeutic strategyImages of E. coli-BSA under inverted fluorescence microscope: Experimental group: anti-streptavidin primary antibody immunofluorescence; Control group: PBS instead of anti-streptavidin primary antibody; A-B: bright field; C-D: DAPI co-localization fluorescence image; E–F: FITC-labeled streptavidin fluorescence; G-H: B and C merged (Scale bar = 50 µm A-H)Back to article page